{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:21:14Z","timestamp":1780482074436,"version":"3.54.1"},"reference-count":56,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/ijmm.2015.2330","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T07:52:16Z","timestamp":1441007536000},"page":"1335-1344","source":"Crossref","is-referenced-by-count":29,"title":["Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis"],"prefix":"10.3892","volume":"36","author":[{"given":"MINGJUN","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENGANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"GENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YANRU","family":"QIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENJIE","family":"DONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XUDONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AN","family":"QIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGZHI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,8,31]]},"reference":[{"key":"key20180107232843_b1-ijmm-36-05-1335","first-page":"169","article-title":"The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells","volume":"29","author":"Kim","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b2-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"key20180107232843_b3-ijmm-36-05-1335","first-page":"1053","article-title":"Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss","volume":"29","author":"Kim","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b4-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3892\/ijmm.2013.1416","article-title":"Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-\u03b1 inhibits titanium particle-induced osteoclastogenesis and bone resorption","volume":"32","author":"Guo","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b5-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3892\/ijmm.2013.1406","article-title":"Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells","volume":"32","author":"Hou","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b6-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"key20180107232843_b7-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107232843_b8-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","article-title":"The cellular and molecular biology of periprosthetic osteolysis","volume":"454","author":"Purdue","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"key20180107232843_b9-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/jor.20190","article-title":"Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(\u2212\/\u2212) mice","volume":"24","author":"Ren","year":"2006","journal-title":"J Orthop Res"},{"key":"key20180107232843_b10-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107232843_b11-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key20180107232843_b12-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"key20180107232843_b13-ijmm-36-05-1335","first-page":"521","article-title":"Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency","volume":"21","author":"Strait","year":"2008","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b14-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/art.21626","article-title":"Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction","volume":"54","author":"Zwerina","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key20180107232843_b15-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1093\/nar\/gkr162","article-title":"Extracellular signal-regulated kinase 1\/2-mediated phosphorylation of p300 enhances myosin heavy chain I\/beta gene expression via acetylation of nuclear factor of activated T cells c1","volume":"39","author":"Meissner","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key20180107232843_b16-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"key20180107232843_b17-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1074\/jbc.M111696200","article-title":"Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling","volume":"277","author":"Mansky","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107232843_b18-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"18840","DOI":"10.3390\/ijms151018840","article-title":"Fucoidan, a sulfated polysaccharide, inhibits osteoclast differentiation and function by modulating RANKL signaling","volume":"15","author":"Kim","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20180107232843_b19-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1091581810376840","article-title":"Effect of astragaloside IV on the general and peripartum reproductive toxicity in Sprague-Dawley rats","volume":"29","author":"Xuying","year":"2010","journal-title":"Int J Toxicol"},{"key":"key20180107232843_b20-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0254-6272(13)60189-2","article-title":"Pharmacological effects of astragaloside IV: A literature review","volume":"33","author":"Ren","year":"2013","journal-title":"J Tradit Chin Med"},{"key":"key20180107232843_b21-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1248\/cpb.c13-00556","article-title":"Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K\/Akt pathway","volume":"62","author":"Jia","year":"2014","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"key20180107232843_b22-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"284025","DOI":"10.1155\/2013\/284025","article-title":"Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats","volume":"2013","author":"Tan","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"key20180107232843_b23-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1681.2008.05059.x","article-title":"Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels","volume":"36","author":"Hu","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key20180107232843_b24-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.imbio.2014.03.005","article-title":"Astragaloside IV attenuates allergic inflammation by regulation Th1\/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in ovalbumin-induced asthma","volume":"219","author":"Huang","year":"2014","journal-title":"Immunobiology"},{"key":"key20180107232843_b25-ijmm-36-05-1335","first-page":"725","article-title":"Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2","volume":"36","author":"Qi","year":"2010","journal-title":"Int J Oncol"},{"key":"key20180107232843_b26-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/08923973.2012.744034","article-title":"Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-\u03baB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells","volume":"35","author":"He","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"key20180107232843_b27-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/0886022X.2013.867798","article-title":"Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells","volume":"36","author":"Wang","year":"2014","journal-title":"Ren Fail"},{"key":"key20180107232843_b28-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ptr.3656","article-title":"Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway","volume":"26","author":"Zheng","year":"2012","journal-title":"Phytother Res"},{"key":"key20180107232843_b29-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cyto.2013.01.008","article-title":"Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-\u03baB-mediated inflammatory genes expression","volume":"61","author":"Gui","year":"2013","journal-title":"Cytokine"},{"key":"key20180107232843_b30-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2012.09.033","article-title":"Astragaloside IV attenuates Toll-like receptor 4 expression via NF-\u03baB pathway under high glucose condition in mesenchymal stem cells","volume":"696","author":"Li","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"key20180107232843_b31-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3892\/ijmm.2014.1741","article-title":"Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase\/ROS\/Akt\/NF-\u03baB pathway under high glucose conditions","volume":"34","author":"Sun","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20180107232843_b32-ijmm-36-05-1335","first-page":"63","article-title":"The osteogenetic effect of astragaloside IV with centrifugating pressure on the OCT-1 cells","volume":"66","author":"Bian","year":"2011","journal-title":"Pharmazie"},{"key":"key20180107232843_b33-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12272-014-0336-2","article-title":"Astragaloside IV possesses antiarthritic effect by preventing interleukin 1\u03b2-induced joint inflammation and cartilage damage","volume":"37","author":"Wang","year":"2014","journal-title":"Arch Pharm Res"},{"key":"key20180107232843_b34-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00709-012-0435-1","article-title":"Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4","volume":"250","author":"Xie","year":"2013","journal-title":"Protoplasma"},{"key":"key20180107232843_b35-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"e34132","DOI":"10.1371\/journal.pone.0034132","article-title":"Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS One"},{"key":"key20180107232843_b36-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00223-007-9077-2","article-title":"Particle-induced osteolysis in three-dimensional micro-computed tomography","volume":"81","author":"Wedemeyer","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"key20180107232843_b37-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.biocel.2012.05.014","article-title":"V-ATPases in osteoclasts: Structure, function and potential inhibitors of bone resorption","volume":"44","author":"Qin","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107232843_b38-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107232843_b39-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bone.2009.10.032","article-title":"Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis","volume":"46","author":"Seo","year":"2010","journal-title":"Bone"},{"key":"key20180107232843_b40-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"key20180107232843_b41-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kappaB in osteoclast and B-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes Dev"},{"key":"key20180107232843_b42-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"key20180107232843_b43-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.3390\/ijms150610605","article-title":"Genistein inhibits osteoclastic differentiation of RAW 264.7 cells via regulation of ROS production and scavenging","volume":"15","author":"Lee","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20180107232843_b44-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamainternmed.2013.3271","article-title":"Sex and risk of hip implant failure: Assessing total hip arthroplasty outcomes in the United States","volume":"173","author":"Inacio","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"Suppl","key":"key20180107232843_b45-ijmm-36-05-1335","first-page":"50","article-title":"A new treatment for post-menopausal osteoporosis: Strontium ranelate","volume":"28","author":"Rizzoli","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"key20180107232843_b46-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1346.030","article-title":"Estrogen regulation of immune cell bone interactions","volume":"1068","author":"Weitzmann","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"key20180107232843_b47-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.11607\/jomi.te40","article-title":"The deception and fallacies of sponsored randomized prospective double-blinded clinical trials: The bisphosphonate research example","volume":"29","author":"Marx","year":"2014","journal-title":"Int J Oral Maxillofac Implants"},{"key":"key20180107232843_b48-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/0004-2730000003039","article-title":"An overview on the treatment of postmenopausal osteoporosis","volume":"58","author":"Maeda","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key20180107232843_b49-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2011-3479","article-title":"Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk","volume":"97","author":"Nakamura","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107232843_b50-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"FREEDOM Trial: Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180107232843_b51-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/erp.12.76","article-title":"Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women","volume":"13","author":"Hiligsmann","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"key20180107232843_b52-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00198-008-0825-6","article-title":"Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis","volume":"20","author":"Meunier","year":"2009","journal-title":"Osteoporos Int"},{"key":"key20180107232843_b53-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcb.10503","article-title":"Phosphatidylinositol 3-kinase coordinately activates the MEK\/ERK and AKT\/NFkappaB pathways to maintain osteoclast survival","volume":"89","author":"Gingery","year":"2003","journal-title":"J Cell Biochem"},{"key":"key20180107232843_b54-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1016\/j.biomaterials.2014.04.006","article-title":"The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway","volume":"35","author":"Liu","year":"2014","journal-title":"Biomaterials"},{"key":"key20180107232843_b55-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.biomaterials.2014.04.044","article-title":"The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-\u03baB and NFATc1 signaling","volume":"35","author":"Zhai","year":"2014","journal-title":"Biomaterials"},{"key":"key20180107232843_b56-ijmm-36-05-1335","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.biomaterials.2008.12.018","article-title":"Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2015.2330\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:58:14Z","timestamp":1515369494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2015.2330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,31]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,8,31]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/ijmm.2015.2330"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2015.2330","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,31]]}}}